Matusow Truth Blog

In connection with www.makepokerlegal.com. Myself, Scott Matusow, and from time to time, Mike "The Mouth" Matusow will be blogging here. All you want to know here.. Enjoy our blog; Scott Matusow

Saturday, June 1, 2013

Video Chart Analysis and Commentary on Trius Therapeutics ($TSRX)

Video Chart Analysis and Commentary on Trius Therapeutics ($TSRX)
Posted by Scott Matusow at 6:58 PM No comments: Links to this post
Reactions: 

Thursday, May 30, 2013

Updated:Trade Call Opinion: $TSRX For a Bounce Back Over $8

Updated:Trade Call Opinion: $TSRX For a Bounce Back Over $8
Posted by Scott Matusow at 11:35 AM No comments: Links to this post
Reactions: 

Tuesday, May 28, 2013

BioDelivery Sciences Primed To Grab Its Share Of The $1.5 Billion Opioid Market - Seeking Alpha

BioDelivery Sciences Primed To Grab Its Share Of The $1.5 Billion Opioid Market - Seeking Alpha
Posted by Scott Matusow at 5:08 AM No comments: Links to this post
Reactions: 

Thursday, May 23, 2013

I bought BioDelivery Sciences (BDSI) on Bullish Chart: Solid Small Cap Spec Investment.

I bought BioDelivery Sciences (BDSI) on Bullish Chart: Solid Small Cap Spec Investment.
Posted by Scott Matusow at 11:24 AM No comments: Links to this post
Reactions: 

Tuesday, May 21, 2013

GTx Pharma Showing Bullish Chart Before Upcoming June Catalyst Data Release

GTx Pharma Showing Bullish Chart Before Upcoming June Catalyst Data Release
Posted by Mike Matusow at 7:51 AM No comments: Links to this post
Reactions: 

Wednesday, May 15, 2013

I bought Antares @ $3.95, I see a move to $4.35 short term

I bought Antares @ $3.95, I see a move to $4.35 short term
Posted by Scott Matusow at 10:02 AM No comments: Links to this post
Reactions: 

Tuesday, May 14, 2013

Significant Near-Term Top-Line Data Catalyst And Platform Technology Should Rally Insmed -- Trefis

Significant Near-Term Top-Line Data Catalyst And Platform Technology Should Rally Insmed -- Trefis
Posted by Scott Matusow at 8:34 AM No comments: Links to this post
Reactions: 

Insmed: Top-Line Data Should Rally Stock | Investing.com

Insmed: Top-Line Data Should Rally Stock | Investing.com
Posted by Scott Matusow at 7:57 AM No comments: Links to this post
Reactions: 

Significant Near-Term Top-Line Data Catalyst And Platform Technology Should Propel Insmed - Seeking Alpha

Significant Near-Term Top-Line Data Catalyst And Platform Technology Should Propel Insmed - Seeking Alpha
Posted by Scott Matusow at 7:12 AM No comments: Links to this post
Reactions: 
Older Posts Home
Subscribe to: Posts (Atom)

Come join our free Poker Room. Tons of cash and prizes!

Come join our free Poker Room. Tons of cash and prizes, and it is free! Vip Memberships also available with even more Cash and Prizes!

Blog Archive

  • ▼  2013 (52)
    • ▼  June (1)
      • Video Chart Analysis and Commentary on Trius Thera...
    • ►  May (10)
    • ►  April (7)
    • ►  March (12)
    • ►  February (10)
    • ►  January (12)
  • ►  2012 (160)
    • ►  December (17)
    • ►  November (18)
    • ►  October (9)
    • ►  September (4)
    • ►  August (11)
    • ►  July (7)
    • ►  June (11)
    • ►  May (15)
    • ►  April (13)
    • ►  March (14)
    • ►  February (23)
    • ►  January (18)
  • ►  2011 (137)
    • ►  November (6)
    • ►  October (3)
    • ►  September (6)
    • ►  August (2)
    • ►  July (2)
    • ►  June (12)
    • ►  May (6)
    • ►  April (23)
    • ►  March (34)
    • ►  February (23)
    • ►  January (20)
  • ►  2010 (27)
    • ►  December (16)
    • ►  November (10)
    • ►  April (1)
  • ►  2009 (4)
    • ►  May (2)
    • ►  April (2)
  • ►  2008 (8)
    • ►  October (1)
    • ►  July (3)
    • ►  June (4)
  • ►  2007 (124)
    • ►  November (3)
    • ►  October (3)
    • ►  September (1)
    • ►  August (5)
    • ►  July (10)
    • ►  June (57)
    • ►  May (4)
    • ►  April (1)
    • ►  March (20)
    • ►  February (20)

Contributors

  • Scott Matusow
  • Mike Matusow

Vistors

Free Web Counter
Free Web Counter